slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 40,651-40,680
Pages 2,019
Rows per page 30
Component
40,651-40,680 of 60,568
36
This is a standard financial disclosure slide for non-GAAP metrics.Factset | Investor Presentation Deck | 37 slides · FactSet
Conference presentation Investor relations 1 hit
37
The table reconciles GAAP EPS to non-GAAP adjusted EPS for both the low and high ends of the fiscal outlook range.Factset | Investor Presentation Deck | 37 slides · FactSet
Conference presentation Investor relations 1 hit
07
Uses a 2x2 layout of text blocks and a small data table to contrast ISS claims with 'Reality'.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Monster (ISS and MindMed's flaws)1 hit
08
The slide highlights MindMed's high compensation relative to poor stock performance.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Monster (ISS and MindMed's flaws)1 hit
24
Freyr | Investor Day Presentation Deck | 29 slidesFreyr | Investor Day Presentation Deck | 29 slides · FREYR
Conference presentation Investor relations Beat · SatisfactionLoop · Why Now1 hit
08
Includes a footnote regarding Complementary Products growth.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
09
Includes a footnote regarding reconciliation of non-GAAP metrics.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
12
Includes operational metrics like business days and branch counts alongside standard P&L items.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
13
Includes supplemental cash flow disclosures and a non-GAAP reconciliation for free cash flow.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
14
The table includes both a bridge-style breakdown and a product-line breakdown of net sales.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
15
The table includes adjustments labeled A through H, which are detailed in the commentary section on the right.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
16
The slide provides a detailed breakdown of adjustments made to Net Income to arrive at Pro Forma Adjusted EBITDA, including non-cash items and one-time costs.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
17
Includes commentary on depreciation/amortization and tax rate normalization.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
18
The table includes a breakdown of specific adjustments (A-E) with corresponding commentary on the right.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
19
The table tracks debt components, total debt, net debt, and leverage ratios (Total Debt/EBITDA and Net Debt/EBITDA) over time.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
20
GMS | Results Presentation Deck | 20 slidesGMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
12
Includes visual examples of exclusive prints and product packaging.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
14
The slide uses a three-column layout to present key performance indicators related to workforce diversity, product sustainability, and environmental impact.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
16
Honest | Investor Conference Presentation Deck | 19 slidesHonest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Financial OverviewLoop · Cost Of Inaction1 hit
07
The slide explains the transition to IFRS 17 and how 'adjusted performance' metrics are calculated.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations 1 hit
11
The slide uses a combination of a biological mechanism diagram, a market data table, and a comparative analysis of current therapy limitations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
14
Clinical trial baseline data table.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
15
The slide provides a breakdown of patient outcomes including completion and withdrawal reasons.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
17
The chart shows a clear reduction in IRAK4 protein levels in both AD and HS patient groups after 28 days of treatment, bringing them down to or below the baseline levels of healthy subjects.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
23
Includes clinical photography, efficacy endpoint table, and biomarker data (cytokines and RNAseq).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
28
Includes clinical efficacy table and RNAseq biomarker reduction chart.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
29
Includes patient profile, clinical efficacy table, before/after photos, and cytokine biomarker tracking.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
30
The table compares KT-474 (Part C) at Day 28 and 42 against external benchmarks at Week 4. Includes extensive footnote citations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit